METASTATIC (STAGE IV) MELANOMA

Clinical trials for METASTATIC (STAGE IV) MELANOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC (STAGE IV) MELANOMA trials appear

Sign up with your email to follow new studies for METASTATIC (STAGE IV) MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for breast cancer patients who run out of options

Disease control Not yet recruiting

This study is testing whether adding a new drug called prifetrastat to the standard hormone therapy fulvestrant can help control advanced breast cancer that has stopped responding to current treatments. It will enroll 51 adults with hormone-sensitive, HER2-negative breast cancer …

Matched conditions: METASTATIC (STAGE IV) MELANOMA

Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

METASTATIC (STAGE IV) MELANOMA

Get alerted when new METASTATIC (STAGE IV) MELANOMA trials appear

New hope for breast cancer patients who run out of options